CPhI Milan is the world's largest pharmaceutical ingredients and technology event, and Datwyler is bringing its full container closure and drug delivery component portfolio to this showcase, engaging manufacturers, CDMOs, and regulatory professionals from across Europe, Asia, and the Americas.
Don't Miss Our Panel Discussion
Robert Lindner, Global Platform Leader, Biologics at Datwyler, joins the panel discussion "Large Volume Drug Delivery Trade Off: The Patient Choice Dilemma," moderated by Clare Beddoes, Head of Drug Delivery at Cambridge Design Partnership.
- Comparing device trade-offs in wear time, injection duration, and patient acceptance between on-body platforms and large-format auto-injectors
- Examining why multiple smart device solutions exist but none have achieved widespread market adoption
- Incorporating patient group perspectives on usability, lifestyle impact, and adherence barriers for volumes exceeding 2mL
Panelists include Sara Stewart, Public Relations Communications Specialist & Patient Advocate; Soren Skov, Senior Human Factors Engineer at Roche; and Noah Flajsing, Associate Director Marketing at BD.
Want to connect?
Connect with our global team of packaging and regulatory experts to explore Datwyler's comprehensive portfolio of:
All reflecting the full scope of modern pharmaceutical packaging needs, supported by Datwyler's "Zero-Defect" approach to faster development timelines and compliant manufacturing outcomes.
